Recapitulating the orthotopic tumour microenvironment using bioluminescent syngeneic models in immune competent mice for checkpoint inhibitor interrogation

被引：0
|
作者：
Papadopoulou, N. [1 ]
Davies, J. [1 ]
Wainwright, L. [1 ]
Wrigley, J. [1 ]
Jiang, S. [1 ]
King, J. [1 ]
Yin, Y. [1 ]
Kumari, J. [1 ]
机构：
[1] Crown Biosci UK Ltd, Oncol, Loughborough, Leics, England
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
329 (PB-09
引用
收藏
页码：E109 / E110
页数：2
相关论文
共 44 条
  • [21] The PARP inhibitor rucaparib activates the STING pathway and enhances antitumor responses of immune checkpoint inhibitors in BRCA deficient syngeneic models
    Minh Nguyen
    Robillard, Liliane
    Lin, Kevin K.
    Harding, Thomas C.
    Simmons, Andrew D.
    CANCER RESEARCH, 2018, 78 (13)
  • [22] STAT3 inhibition enhances the activity of immune checkpoint inhibitors in murine syngeneic tumor models by creating a more immunogenic tumor microenvironment
    Woessner, Rich
    McCoon, Patricia
    Bell, Kirsten
    DuPont, Rachel
    Collins, Mike
    Lawson, Deborah
    Nadella, Prasad
    Pablo, Lourdes
    Reimer, Corinne
    Sah, Vasu
    Lyne, Paul
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [23] Prophylactic In Vivo Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models
    Li, Chang
    Course, Meredith M.
    McNeish, Iain A.
    Drescher, Charles W.
    Valdmanis, Paul N.
    Lieber, Andre
    CANCER RESEARCH, 2020, 80 (03) : 549 - 560
  • [24] USING HYDROGEL MODELS TO RECAPITULATE THE TUMOUR-IMMUNE MICROENVIRONMENT OF AGGRESSIVE GROUP 4 MEDULLOBLASTOMA TUMOURS
    Forder-Denham, Isabelle
    Kerr, Ian
    Jackson, Andrew M.
    Coyle, Beth
    NEURO-ONCOLOGY, 2024, 26
  • [25] Monitoring of Human Lung Tumour Progression Inhibited by TFPI-2 Using Imaging in Mice Orthotopic Models
    Lavergne, M.
    Iochmann, S.
    Blechet, C.
    Lerondel, S.
    Heuze-Vourc'h, N.
    Gaud, G.
    Lemarie, E.
    Le Pape, A.
    Guyetant, S.
    Reverdiau, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S192 - S192
  • [26] Immune-checkpoint inhibitor therapy response evaluation using oncophysics-based mathematical models
    Syed, Mustafa
    Cagely, Matthew
    Dogra, Prashant
    Hollmer, Lauren
    Butner, Joseph D.
    Cristini, Vittorio
    Koay, Eugene J.
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2023, 15 (02)
  • [27] Immune checkpoint inhibitor responses in humanized mouse melanoma models using patient-derived xenografts
    Somasundaram, Rajasekharan
    Bequiri, Marilda
    Li, Ling
    Herlyn, Meenhard
    Kiernan, Meaghan
    Muthumani, Kar
    Choi, Hyeree
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [28] Building a translational pathway using pharmacodynamic and syngeneic tumour models in conjunction with gene expression to enable the development of cancer immune therapies
    Brackenbury, Louise
    Iannitti, Tommaso
    Nunan, Robert
    Harvey, Louise
    Andreae, Clio
    Brackenbury, Louise
    Jenkinson, S. Rhiannon
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [29] Dynamic human immune and tumour cells cross-talk in PDX-humanised mice warrants checkpoint inhibitor cancer immunotherapies assessment
    Poirier, Nicolas
    Vanhove, Bernard
    GUT, 2018, 67 (10) : 1753 - 1754
  • [30] Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses
    Yuen, Vincent Wai-Hin
    Chiu, David Kung-Chun
    Law, Cheuk-Ting
    Cheu, Jacinth Wing-Sum
    Chan, Cerise Yuen-Ki
    Wong, Bowie Po-Yee
    Goh, Chi-Ching
    Zhang, Misty Shuo
    Xue, Helen Do-Gai
    Tse, Aki Pui-Wah
    Zhang, Yan
    Lau, Henry Yee-Hin
    Lee, Derek
    Au-Yeung, Rex K. H.
    Wong, Chun-Ming
    Chak-Lui, Carmen
    JOURNAL OF HEPATOLOGY, 2023, 78 (02) : 376 - 389
12345